Compare NNI & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NNI | LNTH |
|---|---|---|
| Founded | 1978 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.3B |
| IPO Year | 2003 | 2014 |
| Metric | NNI | LNTH |
|---|---|---|
| Price | $140.78 | $84.00 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $140.00 | $87.00 |
| AVG Volume (30 Days) | 131.4K | ★ 546.8K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.94% | N/A |
| EPS Growth | ★ 134.86 | N/A |
| EPS | ★ 11.79 | 3.41 |
| Revenue | N/A | ★ $343,374,000.00 |
| Revenue This Year | $2.28 | N/A |
| Revenue Next Year | $5.38 | $14.19 |
| P/E Ratio | ★ $11.94 | $24.28 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $104.50 | $47.27 |
| 52 Week High | $142.87 | $108.86 |
| Indicator | NNI | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 70.77 | 63.19 |
| Support Level | $128.24 | $72.35 |
| Resistance Level | $141.87 | $84.82 |
| Average True Range (ATR) | 3.05 | 2.24 |
| MACD | 0.83 | 0.11 |
| Stochastic Oscillator | 95.59 | 89.08 |
Nelnet Inc is a United States based company engaged in these four reportable segments; Loan Servicing and Systems focuses on student and consumer loan origination services and servicing, loan origination and servicing-related technology solutions, and outsourcing business services; Education Technology Services and Payments segment provides education services, payment technology, and community management solutions for K-12 schools, institutions, churches, and businesses; Asset Generation and Management segment includes the acquisition and management of student and other loan assets; and Nelnet Bank focuses on the private education and unsecured consumer loan markets. Maximum revenue for the company is generated from its Education Technology Services and Payments segment.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.